TrialJAMA2026

Orforglipron Added to Titrated Insulin Glargine in Type 2 Diabetes: The ACHIEVE-5 Randomized Clinical Trial.

Francesco Giorgino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.